---
title: NorthEast BioLab vs ProBio
slug_a: nebiolab
slug_b: probio
site: cro
review_signal_gate: closed
canonical_path: /compare/nebiolab/probio
generated_by: BioBM Editorial AI
---

# NorthEast BioLab vs ProBio

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

NorthEast BioLab (nebiolab) is listed for cro. Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.

Services: 13. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

ProBio (probio) is listed for both. ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.

Services: 7. Modalities: 7. Indications: 1. Locations: 6. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.